Radiomics Can Distinguish Pediatric Supratentorial Embryonal Tumors, High-Grade Gliomas, and Ependymomas

References

1. 1.↵
   1. Hwang EI,
   2. Kool M,
   3. Burger PC, et al

   . Extensive molecular and clinical heterogeneity in patients with histologically diagnosed CNS-PNET treated as a single entity: a report from the Children’s Oncology Group Randomized ACNS0332 Trial. J Clin Oncol 2018;36:3388–95 doi:10.1200/JCO.2017.76.4720

   CrossRefPubMed
2. 2.↵
   1. Sturm D,
   2. Orr BA,
   3. Toprak UH, et al

   . New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 2016;164:1060–172 doi:10.1016/j.cell.2016.01.015 pmid:26919435

   CrossRefPubMed
3. 3.↵
   1. Braunstein S,
   2. Raleigh D,
   3. Bindra R, et al

   . Pediatric high-grade glioma: current molecular landscape and therapeutic approaches. J Neurooncol 2017;134:541–49 doi:10.1007/s11060-017-2393-0 pmid:28357536

   CrossRefPubMed
4. 4.↵
   1. Jakacki RI,
   2. Burger PC,
   3. Kocak M, et al

   . Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children’s Oncology Group. Pediatr Blood Cancer 2015;62:776–83 doi:10.1002/pbc.25405 pmid:25704363

   CrossRefPubMed
5. 5.↵
   1. Lillard JC,
   2. Venable GT,
   3. Khan NR, et al

   . Pediatric supratentorial ependymoma: surgical, clinical, and molecular analysis. Neurosurgery 2019;85:41–49 doi:10.1093/neuros/nyy239 pmid:29917116

   CrossRefPubMed
6. 6.↵
   1. Louis DN,
   2. Perry A,
   3. Reifenberger G, et al

   . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016;131:803–20 doi:10.1007/s00401-016-1545-1 pmid:27157931

   CrossRefPubMed
7. 7.↵
   1. Louis DN,
   2. Perry A,
   3. Wesseling P, et al

   . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23:1231–51 doi:10.1093/neuonc/noab106 pmid:34185076

   CrossRefPubMed
8. 8.↵
   1. AlRayahi J,
   2. Zapotocky M,
   3. Ramaswamy V, et al

   . Pediatric brain tumor genetics: what radiologists need to know. Radiographics 2018;38:2102–22 doi:10.1148/rg.2018180109 pmid:30422762

   CrossRefPubMed
9. 9.↵
   1. Torre M,
   2. Alexandrescu S,
   3. Dubuc AM, et al

   . Characterization of molecular signatures of supratentorial ependymomas. Mod Pathol 2020;33:47–56 doi:10.1038/s41379-019-0329-2 pmid:31375768

   CrossRefPubMed
10. 10.↵
    1. Lambin P,
    2. Leijenaar RTH,
    3. Deist TM, et al

    . Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 2017;14:749–62 doi:10.1038/nrclinonc.2017.141 pmid:28975929

    CrossRefPubMed
11. 11.↵
    1. Napel S,
    2. Mu W,
    3. Jardim-Perassi BV, et al

    . Quantitative imaging of cancer in the postgenomic era: Radio(geno)mics, deep learning, and habitats. Cancer 2018;124:4633–49 doi:10.1002/cncr.31630 pmid:30383900

    CrossRefPubMed
12. 12.↵
    1. Chaddad A,
    2. Kucharczyk MJ,
    3. Daniel P, et al

    . Radiomics in glioblastoma: current status and challenges facing clinical implementation. Front Oncol 2019;9:374 doi:10.3389/fonc.2019.00374 pmid:31165039

    CrossRefPubMed
13. 13.↵
    1. Dong J,
    2. Li L,
    3. Liang S, et al

    . Differentiation between ependymoma and medulloblastoma in children with radiomics approach. Acad Radiol 2021;28:318–27 doi:10.1016/j.acra.2020.02.012 pmid:32222329

    CrossRefPubMed
14. 14.↵
    1. Lohmann P,
    2. Elahmadawy MA,
    3. Gutsche R, et al

    . FET PET radiomics for differentiating pseudoprogression from early tumor progression in glioma patients post-chemoradiation. Cancers (Basel) 2020;12:3835 doi:10.3390/cancers12123835 pmid:33353180

    CrossRefPubMed
15. 15.↵
    1. Park CJ,
    2. Han K,
    3. Kim H, et al

    . MRI features may predict molecular features of glioblastoma in isocitrate dehydrogenase wild-type lower-grade gliomas. AJNR Am J Neuroradiol 2021;42:448–56 doi:10.3174/ajnr.A6983 pmid:33509914

    Abstract/FREE Full Text
16. 16.↵
    1. Quon JL,
    2. Bala W,
    3. Chen LC, et al

    . Deep learning for pediatric posterior fossa tumor detection and classification: a multi-institutional study. AJNR Am J Neuroradiol 2020;41:1718–25 doi:10.3174/ajnr.A6704 pmid:32816765

    Abstract/FREE Full Text
17. 17.↵
    1. Rodriguez Gutierrez D,
    2. Awwad A,
    3. Meijer L, et al

    . Metrics and textural features of MRI diffusion to improve classification of pediatric posterior fossa tumors. AJNR Am J Neuroradiol 2014;35:1009–15 doi:10.3174/ajnr.A3784 pmid:24309122

    Abstract/FREE Full Text
18. 18.↵
    1. Zhang M,
    2. Wong SW,
    3. Lummus S, et al

    . Radiomic phenotypes distinguish atypical teratoid/rhabdoid tumors from medulloblastoma. AJNR Am J Neuroradiol 2021;42:1702–08 doi:10.3174/ajnr.A7200 pmid:34266866

    Abstract/FREE Full Text
19. 19.↵
    1. Zhou H,
    2. Hu R,
    3. Tang O, et al

    . Automatic machine learning to differentiate pediatric posterior fossa tumors on routine MR imaging. AJNR Am J Neuroradiol 2020;41:1279–85 doi:10.3174/ajnr.A6621 pmid:32661052

    Abstract/FREE Full Text
20. 20.↵
    1. Zwanenburg A,
    2. Vallieres M,
    3. Abdalah MA, et al

    . The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 2020;295:328–38 doi:10.1148/radiol.2020191145 pmid:32154773

    CrossRefPubMed
21. 21.↵
    1. van Griethuysen JJ,
    2. Fedorov A,
    3. Parmar C, et al

    . Computational radiomics system to decode the radiographic phenotype. Cancer Res 2017;77:e104–07 doi:10.1158/0008-5472.CAN-17-0339 pmid:29092951

    Abstract/FREE Full Text
22. 22.↵
    1. Mattonen SA,
    2. Gude D,
    3. Echegaray S, et al

    . Quantitative imaging feature pipeline: a web-based tool for utilizing, sharing, and building image-processing pipelines. J Med Imaging (Bellingham) 2020;7:042803 doi:10.1117/1.JMI.7.4.042803 pmid:32206688

    CrossRefPubMed
23. 23.↵
    1. Fouladi M,
    2. Hunt DL,
    3. Pollack IF, et al

    . Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children’s Cancer Group high-grade glioma study CCG-945. Cancer 2003;98:1243–52 doi:10.1002/cncr.11637 pmid:12973849

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Zamora C,
    2. Huisman TA,
    3. Izbudak I

    . Supratentorial tumors in pediatric patients. Neuroimaging Clin N Am 2017;27:39–67 doi:10.1016/j.nic.2016.08.003 pmid:27889023

    CrossRefPubMed
25. 25.↵
    1. Fangusaro J

    . Pediatric high-grade glioma: a review and update on tumor clinical characteristics and biology. Front Oncol 2012;2:105 doi:10.3389/fonc.2012.00105 pmid:22937526

    CrossRefPubMed
26. 26.↵
    1. Mackay A,
    2. Burford A,
    3. Carvalho D, et al

    . Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 2017;32:520–37.e5 doi:10.1016/j.ccell.2017.08.017 pmid:28966033

    CrossRefPubMed
27. 27.↵
    1. Mangalore S,
    2. Aryan S,
    3. Prasad C, et al

    . Imaging characteristics of supratentorial ependymomas: study on a large single institutional cohort with histopathological correlation. Asian J Neurosurg 2015;10:276–81 doi:10.4103/1793-5482.162702 pmid:26425155

    CrossRefPubMed
28. 28.↵
    1. Reni M,
    2. Gatta G,
    3. Mazza E, et al

    . Ependymoma. Crit Rev Oncol Hematol 2007;63:81–89 doi:10.1016/j.critrevonc.2007.03.004 pmid:17482475

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Ellison DW,
    2. Kocak M,
    3. Figarella-Branger D, et al

    . Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed 2011;10:7 doi:10.1186/1477-5751-10-7 pmid:21627842

    CrossRefPubMed
30. 30.↵
    1. Jaju A,
    2. Hwang EI,
    3. Kool M, et al

    . MRI features of histologically diagnosed supratentorial primitive neuroectodermal tumors and pineoblastomas in correlation with molecular diagnoses and outcomes: a report from the Children’s Oncology Group ACNS0332 Trial. AJNR Am J Neuroradiol 2019;40:1796–1803 doi:10.3174/ajnr.A6253 pmid:31601576

    Abstract/FREE Full Text
31. 31.↵
    1. Borja MJ,
    2. Plaza MJ,
    3. Altman N, et al

    . Conventional and advanced MRI features of pediatric intracranial tumors: supratentorial tumors. AJR Am J Roentgenol 2013;200:W483–503 doi:10.2214/AJR.12.9724 pmid:23617516

    CrossRefPubMed
32. 32.↵
    1. Chawla A,
    2. Emmanuel JV,
    3. Seow WT, et al

    . Paediatric PNET: pre-surgical MRI features. Clin Radiol 2007;62:43–52 doi:10.1016/j.crad.2006.09.008 pmid:17145263

    CrossRefPubMed
33. 33.↵
    1. Dai AI,
    2. Backstrom JW,
    3. Burger PC, et al

    . Supratentorial primitive neuroectodermal tumors of infancy: clinical and radiologic findings. Pediatr Neurol 2003;29:430–34 doi:10.1016/S0887-8994(03)00313-8 pmid:14684239

    CrossRefPubMed
34. 34.↵
    1. Klisch J,
    2. Husstedt H,
    3. Hennings S, et al

    . Supratentorial primitive neuroectodermal tumours: diffusion-weighted MRI. Neuroradiology 2000;42:393–98 doi:10.1007/s002340000318 pmid:10929296

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Nowak J,
    2. Seidel C,
    3. Pietsch T, et al

    . Systematic comparison of MRI findings in pediatric ependymoblastoma with ependymoma and CNS primitive neuroectodermal tumor not otherwise specified. Neuro Oncol 2015;17:1157–65 doi:10.1093/neuonc/nov063 pmid:25916887

    CrossRefPubMed